home / stock / lly / lly articles

LLY Articles, Eli Lilly and Company - From 01/22/24

Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today | Benzinga

Eli Lilly (NYSE:LLY) has outperformed the market over the past 20 years by 4.2% on an annualized basis producing an average annual return of 11.72%...
Healthcare Giant Eli Lilly Under FDA Lens Again For Manufacturing Lapses | Benzinga

Eli Lilly And Co (NYSE:LLY) faces renewed scrutiny as the FDA inspectors reveal additional manufacturing issues at its Branchburg, New Jersey ...

Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering? | Benzinga

Diabetes treatments such as Ozempic and Mounjaro became the blockbuster drugs of 2023 thanks to their popularity as weight-loss remedies. Prices fo...

Eli Lilly's Blockbuster Diabetes Drug Mounjaro Set To Enter New Markets Amid Manufacturing Boost | Benzinga

Eli Lilly & Company (NYSE:LLY) has unveiled plans to introduce its weight-loss drug Mounjaro (tirzepatide) in new countries this year whil...
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns | Benzinga

A new era in Alzheimer’s diagnosis is on the horizon as Dr. Suzanne Schindler and her team at Washington University School of Medic...

FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts | Benzinga

Following a preliminary review, the U.S. Food and Drug Administration found no evidence that weight-loss drugs cause suicidal thoughts. What To Kno...

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo and Lilly's Dominance | Benzinga

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positionin...
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance | Benzinga

Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positionin...

Bring On The Competition In Obesity Drugs: Novo Nordisk CEO Optimistic About Prolonged Patient Adherence to Obesity Drug Wegovy | Benzinga

Lars Fruergaard Jorgensen, CEO of Novo Nordisk A/S (NYSE: NVO), shared insights during the JPMorgan Healthcare conference, highlighting W...

Pfizer's Aggressive Stance In Obesity Drugs: CEO Albert Bourla Confirms Bold Bet Despite Prior Drug Hurdles | Benzinga

Monday, at the JP Morgan Healthcare Conference, Pfizer Inc (NYSE: PFE) CEO Albert Bourla expressed that the company is det...
Previous 10 Next 10